Post-operative Monitoring of Gastric Cancer
Launched by SUZHOU HUHU HEALTH & TECHNOLOGY INC. · Jun 15, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new, simple way to keep track of stomach (gastric) cancer after surgery using a special test that looks for certain markers in the body without needing invasive procedures. The goal is to see how well this new test works in monitoring patients who have had surgery for gastric cancer.
Adults over 18 who have stomach discomfort and are visiting the Gastric Surgery Department at the study center may be eligible to join, especially if they have had or will have a gastroscopy (a procedure where a thin tube with a camera looks inside the stomach) or tissue tests done there. People with serious health problems like heart, liver, or kidney issues, previous cancer, certain infections, or those already receiving specific immune-related treatments cannot join. Participants will be asked to provide samples for the test and will need to understand and sign a consent form. This study is currently enrolling patients and aims to help find easier, less invasive ways to monitor gastric cancer after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Subject age over 18.
- • 2. Subject has stomach discomfort, and seek medical attention at the Gastric Surgery Department of our center.
- • 3. Subject has or will have gastroscopy and/or pathological examination results at this center.
- • 4. Subject must be able to fully understand the informed consent form and be able to personally sign it.
- Exclusion Criteria:
- • 1. Subject has serious heart, liver, kidney dysfunction, or mental illness.
- • 2. Subject diagnosed previously with any kind of malignant tumor.
- • 3. Subject is known to be infected with HIV or other related diseases (considering interference from the use of immune drugs).
- • 4. Subject is receiving targeted drugs, immunosuppressants, immunomodulators, and biological therapies.
- • 5. Researchers believe that subject is not suitable for enrollment.
- • 6. Subject can not supply sufficient sample to complete this experiment.
About Suzhou Huhu Health & Technology Inc.
Suzhou Huhu Health & Technology Inc. is a pioneering clinical trial sponsor dedicated to advancing innovative healthcare solutions through rigorous research and development. Based in Suzhou, China, the company specializes in conducting clinical trials that focus on novel therapeutics and medical technologies, aiming to improve patient outcomes and enhance quality of life. With a commitment to scientific integrity and collaboration, Suzhou Huhu Health & Technology Inc. leverages cutting-edge methodologies and a robust network of healthcare professionals to facilitate the efficient and effective progression of clinical studies, ensuring adherence to the highest regulatory standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Trial Officials
Dazhi Xu, MD., PhD,
Principal Investigator
Fudan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported